Sandrine Egron

Sandrine Egron currently serves as an Investment Director at 50 Partners, where she focuses on identifying and supporting early-stage startups operating within the healthcare and innovation sectors. Holding a PhD, she leverages her advanced academic background and scientific expertise to evaluate complex medical technologies, digital health platforms, and emerging therapeutic solutions for potential venture capital funding. In her capacity at the investment firm, she is responsible for conducting rigorous due diligence, assessing market viability, and guiding portfolio companies through their critical growth phases. Her professional mandate involves bridging the gap between scientific research and commercial application, ensuring founders have the strategic resources necessary to scale their healthcare enterprises. Egron’s current focus remains centered on deploying capital into high-potential healthcare ventures and fostering technological advancements that address unmet clinical needs across the broader medical industry.